For example, chemotherapeutic agents that inhibit PTEN signaling or related pathways, such as PI3K-AKT, mTOR and NF-1 (e.g., rapamycin and everolimus), are potential candidates for treating several manifestations of autism [28]. Here, MTOR is linked to autism.